A groundbreaking approach to cancer therapy targeting the neddylation pathway offers new hope for aggressive blood cancers like mantle cell lymphoma.
Exploring how targeting DCN1-mediated neddylation offers new hope for lung squamous cell carcinoma treatment through innovative small-molecule inhibitors.
Discover how targeting neddylation with MLN4924 could overcome cisplatin resistance in ovarian cancer, offering new hope for patients with recurrent disease.